Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats

Experimental and Clinical Cardiology

Volumn 12, Issue 4, 2007, Pages 179-187

  Rao, Pragada Rajeswara ^a   Viswanath, Routhu Kasi ^a  

^a ANDHRA UNIVERSITY   (India)

Author keywords

Infarct size; Myocardial infarction; Reperfusion injury; Silymarin

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATINE KINASE; CREATINE KINASE ISOENZYME; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; MYELOPEROXIDASE; RAMIPRIL; SILYMARIN; SUPEROXIDE DISMUTASE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROCARDIOGRAPHY MONITORING; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; MEAN ARTERIAL PRESSURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RAT; STOMACH LAVAGE;

EID: 37549049744     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Hansen PR. Myocardial reperfusion injury: Experimental evidence and clinical relevance. Eur Heart J 1995;16:734-40.
2. Ferrari R, Alfieri O, Curello S, et al. Occurrence of oxidative stress during reperfusion of the human heart. Circulation 1990;81:201-11.
3. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res 1986;58:331-40.
4. Curello S, Ceconi C, Medici D, Ferrari R. Oxidative stress during myocardial ischemia and reperfusion: Experimental and clinical evidences, J Appl Cardiol 1986;1:311-27.
5. Mohanty I, Singh Arya D, Dinda A, Joshi S, Talwar KK, Gupta SK. Protective effects of Curcuma longa on ischemia-reperfusion induced myocardial injuries and their mechanisms. Life Sci 2004;75:1701-11.
6. Hearse DJ. Prospects for antioxidant therapy in cardiovascular medicine. Am J Med 1991;91:118S-21S.
7. Bernier M, Manning AS, Hearse DJ. Reperfusion arrhythmias: Dose-related protection by anti-free radical interventions. Am J Physiol 1989;256:H1344-H52.
8. Ahmed KKM, Rana AC, Dixit VK. Effect of Calotropis procera latex on isoproterenol induced myocardial infarction in albino rats. Phytomedicine 2004;11:327-30.
9. Manikandan P, Sumitra M, Aishwarya S, Manohar BM, Lokanadam B, Puvanakrishnan R. Curcumin modulates free radical quenching in myocardial ischemia in rats. Int J Biochem Cell Biol 2004;36:1967-80.
10. Karthikeyan K, Bai BR, Gauthaman K, Sathish KS, Devaraj SN. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemia reperfusion injury. Life Sci 2003;73:2727-39.
11. Saravanan G, Prakash J. Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats. J Ethnopharmacol 2004;94:155-8.
12. Senthil kumar SH, Anandan R, Devaki T, Santhosh Kumar M. Cardioprotective effects of Picrorrhiza kurroa against isoproterenol-induced myocardial stress in rats. Fitoterapia 2001;72:402-5.
13. Kurian GA, Philip S, Varghese T. Effect of aqueous extract of Desmodium gangeticum DC root in the severity of myocardial infarction. J Ethnopharmacol 2005;97:457-61.
14. Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK, Maulik SK. Effect of chronic treatment with bark of Terminalia arjuna: A study on the isolated ischemic-reperfused rat heart. J Ethnopharmacol 2001;75:197-201.
15. Nirmala C, Puvanakrishnan R. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 1996;159:85-93.
16. Sharma M, Kishore K, Gupta SK, Joshi S, Arya DS. Cardioprotective potential of Ocimum sanctum in isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 2001;225:75-83.
17. Gupta SK, Mohanty I, Talwar KK, et al. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: A hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem 2004;260:39-47.
18. Sumitra M, Manikandan P, Kumar DA, et al. Experimental myocardial necrosis in rats: Role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol Cell Biochem 2001;224:135-42.
19. Suchalatha S, Shyamala Devi CS. Protective effect of Terminalia chebula against experimental myocardial injury by isoproterenol. Indian J Exp Biol 2004;42:174-8.
20. Pragada RR, Veeravalli KK, Chowdary KP, Routhu KV. Cardioprotective activity of Hydrocotyle asiatica L. in ischemia-reperfusion induced myocardial infarction in rats. J Ethnopharmacol 2004;93:105-8.
21. Pepping J. Milk thistle: Silybum marianum. Am J Health System Pharm 1999;56:1195-7.
22. Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trail of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989;9:105-13.
23. Salmi HA, Sarna S. Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study. Scand J Gastroenterol 1982;17:517-21.
24. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D, Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 1997;26:643-9.
25. Carini R, Comoglio A, Albano E, Poli G. Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phosholipid complex IdB 1016. Biochem Pharmacol 1992;43:2111-5.
26. Velussi M, Cernigoi AM, De Monte A, Dapas F, Caffau C, Zilli M. Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol 1997;26:871-9.
27. Chatterjee ML, Agarwal R, Mukhtar H. Ultraviolet B radiation-induced DNA lesions in mouse epidermis: An assessment using a novel 32P-postlabelling technique. Biochem Biophys Res Commun 1996;229:590-5.
28. Lahiri-Chatterjee M, Katiyar SK, Mohan RR, Agarwal R. A flavonoid antioxidant silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Res 1999;59:622-32.
29. Skottová N, Krecman V, Simánek V. Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro. Phytotherapy Res 1999;13:535-7.
30. Dehmlow C, Erhard J, de Groot H. Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology 1996;23:749-54.
31. Dehmlow C, Murawski N, de Groot H. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sci 1996;58:1591-600.
32. Mira L, Silva M, Manso CF. Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem Pharmacol 1994;48:753-9.
33. Ahmad N, Gali H, Javed S, Agarwal R. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and pertubation in cell cycle progression. Biochem Biophys Res Commun 1998;247:294-301.
34. Onat D, Boscoboinik D, Azzi A, Basaga H. Effect of alpha-tocopherol and silybin dihemisuccinate on the proliferation of human skin fibroblasts. Biotechnol Appl Biochem 1999;29:213-5.
35. Saliou C, Kitazawa M, McLaughlin L, et al. Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line. Free Radic Biol Med 1999;26:174-83.
36. Soto C, Recoba R, Barrón H, Alvarez C, Favari L. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp Biochem Physiol C Toxicol Pharmacol 2003;136:205-12.
37. Müzes G, Deák G, Láng I, Nékám K, Niederland V, Fehér J. [Effect of silymarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol).] Orv Hetil 1990;131:863-6.
38. Láng I, Deák G, Müzes G, Prónai L, Fehér J. Effect of the natural bioflavonoid antioxidant silymarin on superoxide dismutase (SOD) activity and expression in vitro. Biotechnol Ther 1993;4:263-70.
39. Rao PR, Kumar VK, Viswanath RK, Subbaraju GV. Cardioprotective activity of alcoholic extract of Tinospora cordifolia in ischemia-reperfusion induced myocardial infarction in rats. Biol Pharm Bull 2005;28:2319-22.
40. Johnson G 3rd, Tsao P, Lefer AM. Synergism between superoxide dismutase and sodium nitrate in cardioprotection following ischemia and reperfusion. Am Heart J 1990;119:530-8.
41. Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: Validation of triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600.
42. Gobel, FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation 1978;57:549-56.
43. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212-6.
44. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
45. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
46. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249:7130-9.
47. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21:130-2.
48. Aebi H, Catalase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Academic Press: New York 1974;673-84.
49. Ohkawa H, Ohishi N, Yagi K, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
50. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985;14:157-67.
51. Weyrich AS, Ma XL, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279-88.
52. Morazzoni P, Bombardelli E. Silybum marianum (Carduus marianus). Fitoterapia 1995;66:3-42.
53. Valenzuela A, Guerra R, Videla LA. Antioxidant properties of the flavonoids silybin and (+)-cyanidanol-3: Comparison with butylated hydroxyanisole and butylated hydroxytoluene. Planta Med 1986;52:438-40.
54. Comoglio A, Leonarduzzi G, Carini R, et al. Studies on the antioxidant and free radical scavenging properties of IdB 1016 a new flavanolignan complex. Free Radic Res Commun 1990; 11:109-15.
55. Skottová N, Krecman V. Dietary silymarin improves removal of low density lipoproteins by the perfused rat liver. Acta Univ Palacki Olomuc Fac Med 1998;141:39-40.
56. Skottová N, Krecman V. Silymarin as a potential hypocholesterolaemic drug. Physiol Res 1998;47:1-7.
57. Kang JS, Jeon YJ, Park SK, Yang KH, Kim HM. Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin. Biochem Pharmacol 2004;67:175-81.
58. Sanhueza J, Valdes J, Campos R, Garrido A, Valenzuela A. Changes in the xanthine dehydrogenase/xanthine oxidase ratio in the rat kidney subjected to ischemia-reperfusion stress: Preventive effect of some flavonoids. Res Commun Chem Pathol Pharmacol 1992;78:211-8.
59. Muriel P, Garciapiña T, Perez-Alvarez V, Mourelle M. Silymarin protects against paracetamol-induced lipid peroxidation and liver damage. J Appl Toxicol 1992;12:439-42.
60. Haková H, Misúrová E, Kropácová K. The effect of silymarin on concentration and total content of nucleic acids in tissues of continuously irradiated rats. Vet Med (Praha) 1996; 41:113-9.
61. Yim MB, Chock PB, Stadtman ER. Copper, zinc superoxide dismutase catalyzes hydroxy radical production from hydrogen peroxide. Proc Natl Acad Sci U S A 1990;87:5006-10.
62. Harman D. The aging process: Major risk factor for disease and death. Proc Natl Acad Sci U S A 1991;88:5360-3.
63. Mueller EA, Griffin WS, Wildenthal K. Isoproterenol-induced cardiomyopathy: Changes in cardiac enzymes and protection by methylprednisolone. J Mol Cell Cardiol 1977;9:565-78.
64. Lombardini JB. Effects of isoproterenol and methoxamine on the contents of taurine in rat tissues. J Pharmacol Exp Ther 1980;213:399-405.